|
KMID : 0880220090470040498
|
|
Journal of Microbiology
2009 Volume.47 No. 4 p.498 ~ p.505
|
|
|
Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: Implications for the vaccine development
|
|
Cheng Yan
Feng Youjun
Luo Ping
Gu Jiang
Yu Shu
Zhang Wei-jun
Liu Yan-qing
Wang Qing-xu
Zou Quan-ming
Mao Xu-hu
|
|
|
Abstract
|
|
|
|
Shiga toxin 2 (Stx2) is a major virulence factor for enterohemorrhagic Escherichia coli (EHEC), which is encoded by λ lysogenic phage integrated into EHEC chromosome. Stx2Al, Al subunit of Stx2 toxin has gathered extensive concerns due to its potential of being developed into a vaccine candidate. However, the substantial progress is hampered in part for the lack of a suitable in vitro expression system. Here we report use of the prokaryotic system pET-28a::espA-Stx2Al/BL21 to carry out the fusion expression of Stx2Al which is linked to E. coli secreted protein A (EspA) at its N-terminus. Under the IPTG induction, EspA-Stx2Al fusion protein in the form of inclusion body was obtained successfully, whose expression level can reach about 40% of total bacterial protein at 25°C, much higher than that at 37°C. Western blot test suggested the refolded fusion protein is of excellent immuno-reactivity with both monoclonal antibodies, which are specific to EspA and Stx2Al, respectively. Anti-sera from Balb/c mice immunized with the EspA-Stx2Al fusion protein were found to exhibit strong neutralization activity and protection capability in vitro and in vivo. These data have provided a novel feasible method to produce Stx2Al in large scale in vitro, which is implicated for the development of multivalent subunit vaccines candidate against EHEC 0157:H7 infections.
|
|
|
KEYWORD
|
|
|
EHEC O157:H7, EspA, Stx2A1, fusion protein, vaccine
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|